5. Amgen

Total Ad Spend: $229.3 million
Television: $164 million
Magazine: $52.1 million
Other: $13.2 million

Amgen ($AMG) and Pfizer ($PFE), which shared marketing of the anti-inflammatory drug Enbrel in North America for years, dissolved their pact last year as Pfizer moved ahead with a competing treatment. Not about to let the top-selling drug lose momentum, Amgen pushed it in several different campaigns.

In the spotlight

Enbrel for arthritis, $127.1 million
Prolia, $60 million
Enbrel for psoriasis, $42.1 million



Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.